1. Home
  2. CTMX vs KOPN Comparison

CTMX vs KOPN Comparison

Compare CTMX & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • KOPN
  • Stock Information
  • Founded
  • CTMX 2008
  • KOPN 1984
  • Country
  • CTMX United States
  • KOPN United States
  • Employees
  • CTMX N/A
  • KOPN N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • KOPN Semiconductors
  • Sector
  • CTMX Health Care
  • KOPN Technology
  • Exchange
  • CTMX Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • CTMX 62.3M
  • KOPN 282.1M
  • IPO Year
  • CTMX 2015
  • KOPN 1992
  • Fundamental
  • Price
  • CTMX $0.80
  • KOPN $1.66
  • Analyst Decision
  • CTMX Buy
  • KOPN Strong Buy
  • Analyst Count
  • CTMX 6
  • KOPN 4
  • Target Price
  • CTMX $5.77
  • KOPN $2.63
  • AVG Volume (30 Days)
  • CTMX 731.5K
  • KOPN 11.0M
  • Earning Date
  • CTMX 03-10-2025
  • KOPN 03-13-2025
  • Dividend Yield
  • CTMX N/A
  • KOPN N/A
  • EPS Growth
  • CTMX N/A
  • KOPN N/A
  • EPS
  • CTMX 0.16
  • KOPN N/A
  • Revenue
  • CTMX $126,617,000.00
  • KOPN $44,266,305.00
  • Revenue This Year
  • CTMX $22.55
  • KOPN $21.20
  • Revenue Next Year
  • CTMX N/A
  • KOPN $13.55
  • P/E Ratio
  • CTMX $4.93
  • KOPN N/A
  • Revenue Growth
  • CTMX 33.66
  • KOPN 0.60
  • 52 Week Low
  • CTMX $0.75
  • KOPN $0.56
  • 52 Week High
  • CTMX $5.85
  • KOPN $2.79
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 41.61
  • KOPN 51.45
  • Support Level
  • CTMX $0.75
  • KOPN $1.58
  • Resistance Level
  • CTMX $0.98
  • KOPN $1.94
  • Average True Range (ATR)
  • CTMX 0.06
  • KOPN 0.18
  • MACD
  • CTMX 0.00
  • KOPN -0.03
  • Stochastic Oscillator
  • CTMX 20.13
  • KOPN 29.79

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: